Back

Diuretic use in pregnancy: data from the ESC Registry of Pregnancy and Cardiac disease (ROPAC)

27 August 2023 (17:15 - 17:40)
Organised by: Logo
Congress Presentation Part of: Pregnancy: treatment and outcomes Pregnancy and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Mrs Anneroos van der Zande

Rotterdam (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Effects on reduction of morbidity and mortality in ACHD population of childbearing age as a result of ESC Guidelines
Doctor V. Lennie Labayru (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
Women's heart clinics to prevent cardiovascular disease in women with pregnancy-related risk factors: a prospective study
Miss S. Marschner (Sydney, AU)
Abstract Slides Video
Presentation thumbnail
Maternal myocardial recovery twelve months post-partum in women with pregnancies complicated by gestational diabetes or preeclampsia - single center, longitudinal cohort study
Doctor S. Thiru (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
Improving outcomes from paediatric cardiac arrest in low resource setting
Doctor F. Ahmad (Colchester, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Pregnancy: treatment and outcomes

The Event

Event poster

ESC Congress 2023

27 August 2023 17:15 CET
You may be interested in
thumbnail
Congress Presentation
ACE inhibitor and angiotensin receptor blocker use during pregnancy: data from the ESC Registry of pregnancy and cardiac disease (ROPAC)
thumbnail
Congress Presentation
Risks of antihypertensive treatment use in different periods of pregnancy
thumbnail
Congress Presentation
Antihypertensive treatment during pregnancy and maternal and fetal outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources